I am excited to announce the publication of our 2023 impact report, which can be found here.
Since joining as CEO this past spring, I have been nothing short of amazed at our team and partners and the manner in which we are redefining how cancer care can and should be delivered based on patient preferences. I love this stage of a company where you can take a vision and turn it into an organization poised for significant growth. In 2024, we will continue to focus on achieving strong clinical outcomes and deliver an exceptional experience for patients and care teams around the country.
To our Board of Directors – thank you for your continued support and leadership.
To our Virtual Care Team – you are the heart and soul of our mission. Thank you for being at the forefront of caring for our patients.
To the entire RC Team – celebrate our wins, continue to embrace a learning mindset as well as our sense of urgency, and let’s make this happen. I am inspired by each of your talents.
I hope 2024 inspires us all to solve big problems. Together, our limits know no bounds.
Cheers,
Dan Nardi, CEO
